This report of Kantor that somebody placed here are really disturbing.
obvious they have their criteria to define % of risk based in other trials and phase 3 ‘s
they estimate in 40% . This us much less than i thought the chances of
i would appreciate if the posters here (have two that usually have very complete and deep quality posts)that have much more knowledge than me in this area can address please the subject
> their high optimism x this 40% reality placed by kantor
(and please dont shoot me ... im in side lines with high interest to buy back again.
cato
MSB Trading - 2019, page-2789
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.060(5.83%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.10 | $1.03 | $4.925M | 4.571M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7260 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 67541 | 7 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |